Studies of COVID-19 patients have observed that adaptive immune response limits COVID-19 disease severity and balanced CD4+ T cell, CD8+ T cell, and antibody responses are protective, significantly associated with milder disease. The gene discussed is CD4; the disease is COVID-19.